Related Experiment Video
Updated: Jun 15, 2026

12:19
Three-Dimensional (3D) Tumor Spheroid Invasion Assay
Published on: May 1, 2015
[Expression of integrin beta1 in squamous cell carcinoma]
Song-mei Geng1, Lan Li, Qian-qian Wang
1Department of Dermatology, Second Hospital Affiliated to Xi'an Jiaotong University, Xi'an 710004, China. gsm312@yahoo.com
Summary
Integrin beta1 expression varies in squamous cell carcinoma (SCC) and SCC A431 cells. Its levels decrease with increased tumor cell differentiation, suggesting a role in SCC initiation and cancer stem cells.
Area of Science:
- Oncology
- Cell Biology
- Biochemistry
Background:
- Squamous cell carcinoma (SCC) is a common cancer type.
- Integrins are cell surface receptors involved in cell adhesion and signaling.
- Cancer stem cells are implicated in tumor initiation, progression, and recurrence.
Purpose of the Study:
- To investigate the expression patterns of integrin beta1 in SCC.
- To explore the correlation between integrin beta1 and stem cell markers in SCC.
- To understand the role of integrin beta1 in SCC development.
Main Methods:
- Immunohistochemistry and cell staining were used to detect integrin beta1 expression in SCC tissues and A431 cells.
- SCC cells were induced to differentiate using all-trans-retinoic acid (ATRA).
- Quantitative real-time PCR (RT-PCR) was employed to assess changes in integrin beta1 mRNA levels post-ATRA treatment.
Main Results:
- Integrin beta1 exhibited heterogeneous expression in SCC tissues, localized to basal-like cells and island-like structures.
- Poorly differentiated SCC showed increased and diffuse integrin beta1-positive cells compared to highly differentiated SCC.
- ATRA treatment significantly reduced integrin beta1 mRNA levels in A431 cells.
Conclusions:
- Integrin beta1 displays heterogeneous expression in SCC and SCC A431 cells.
- Decreased integrin beta1 expression correlates with increased tumor cell differentiation.
- Integrin beta1 is potentially linked to the initiation of SCC and the presence of cancer stem cells.
Related Concept Videos
Integrins
Animal and protozoan cells do not have cell walls to help maintain shape and provide structural stability. Instead, these eukaryotic cells secrete a sticky mass of carbohydrates and proteins into the spaces between adjacent cells. This network of proteins and molecules is called an extracellular matrix or ECM.
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
Activation of Integrins
Integrins bind ligands and transmit information from outside the cell to inside or vice-versa through an "outside-in signaling" or "inside-out signaling."
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding events provide an effective stimulus.
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding events provide an effective stimulus.
Intracellular Signaling Affects Focal Adhesions
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
Selectins
Cell adhesion is an essential aspect of multicellularity. While stable cell interactions usually occur between cells of the same type, transient cell interactions occur between cells of different tissue types, such as between neutrophils and endothelial cells. Selectins are one class of cell adhesion molecules (CAMs) that bind carbohydrate ligands to form transient cell adhesion. They are rod-like proteins with a long extracellular part of variable length ending with the lectin domain, which...
Immunoglobulin-like Cell Adhesion Molecules
Immunoglobulin-like cell adhesion molecules or Ig-CAMs are a versatile group of cell surface glycoproteins belonging to the immunoglobulin protein superfamily. Ig-CAMs possess the characteristic immunoglobulin protein domains and other domains such as the fibronectin type III domain. The Ig domains are glycosylated to varying degrees in different Ig-CAMs.
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

